| Multifunctional skin‐like electronics for quantitative, clinical monitoring of cutaneous wound healing Y Hattori, L Falgout, W Lee, SY Jung, E Poon, JW Lee, I Na, A Geisler, ... Advanced healthcare materials 3 (10), 1597-1607, 2014 | 284 | 2014 |
| The tongue enables computer and wheelchair control for people with spinal cord injury J Kim, H Park, J Bruce, E Sutton, D Rowles, D Pucci, J Holbrook, ... Science translational medicine 5 (213), 213ra166-213ra166, 2013 | 136 | 2013 |
| Malignancy risk and recurrence with psoriasis and its treatments: a concise update S Geller, H Xu, M Lebwohl, B Nardone, ME Lacouture, M Kheterpal American journal of clinical dermatology 19, 363-375, 2018 | 117 | 2018 |
| Mesotherapy for skin rejuvenation: assessment of the subepidermal low‐echogenic band by ultrasound evaluation with cross‐sectional B‐mode scanning F Lacarrubba, A Tedeschi, B Nardone, G Micali Dermatologic therapy 21, S1-S5, 2008 | 108 | 2008 |
| Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study B Nardone, S Majewski, AS Kim, T Kiguradze, EM Martinez-Escala, ... Drug safety 40, 249-255, 2017 | 84 | 2017 |
| Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report B Nardone, E Saddleton, AE Laumann, BJ Edwards, DW Raisch, ... Pediatric radiology 44, 173-180, 2014 | 82 | 2014 |
| Life-threatening dermatologic adverse events in oncology AC Rosen, Y Balagula, DW Raisch, V Garg, B Nardone, N Larsen, ... Anti-cancer drugs 25 (2), 225-234, 2014 | 76 | 2014 |
| Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, ... PeerJ 5, e3020, 2017 | 75 | 2017 |
| The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life. B Nardone, JR Hensley, L Kulik, DP West, M Mulcahy, A Rademaker, ... Journal of drugs in dermatology: JDD 11 (11), e61-5, 2012 | 73 | 2012 |
| Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis SM Belknap, I Aslam, T Kiguradze, WH Temps, PR Yarnold, J Cashy, ... JAMA dermatology 151 (6), 600-606, 2015 | 72 | 2015 |
| Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event MD Gandhi, AM Evens, TS Fenske, P Hamlin, B Coiffier, A Engert, ... Blood, The Journal of the American Society of Hematology 123 (18), 2895-2897, 2014 | 72 | 2014 |
| An open‐label tolerability and efficacy study of an aluminum sesquichlorhydrate topical foam in axillary and palmar primary hyperhidrosis D Innocenzi, A Ruggero, L Francesconi, F Lacarrubba, B Nardone, ... Dermatologic Therapy 21, S27-S30, 2008 | 71 | 2008 |
| Validation of International Classification of Disease Ninth Revision codes for atopic dermatitis DY Hsu, P Dalal, KA Sable, N Voruganti, B Nardone, DP West, ... Allergy 72 (7), 1091-1095, 2017 | 70 | 2017 |
| Assessment of the tongue-drive system using a computer, a smartphone, and a powered-wheelchair by people with tetraplegia J Kim, H Park, J Bruce, D Rowles, J Holbrook, B Nardone, DP West, ... IEEE Transactions on Neural Systems and Rehabilitation Engineering 24 (1), 68-78, 2015 | 56 | 2015 |
| Melanoma associated with tumour necrosis factor‐α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project B Nardone, JA Hammel, DW Raisch, LL Weaver, D Schneider, DP West British Journal of Dermatology 170 (5), 1170-1172, 2014 | 51 | 2014 |
| Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the … DW Raisch, V Garg, R Arabyat, X Shen, BJ Edwards, FH Miller, JM McKoy, ... Expert opinion on drug safety 13 (1), 15-23, 2014 | 51 | 2014 |
| A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas C Cooper, JD Wayne, EM Damstetter, M Martini, J Gordon, J Guitart, ... Journal of the American Academy of Dermatology 69 (5), 693-699, 2013 | 48 | 2013 |
| Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysis B Nardone, S Wu, BC Garden, DP West, LM Reich, ME Lacouture Clinical Lymphoma Myeloma and Leukemia 13 (4), 424-429, 2013 | 46 | 2013 |
| Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients B Nardone, K Nicholson, M Newman, J Guitart, P Gerami, N Talarico, ... Clinical Cancer Research 16 (17), 4452-4460, 2010 | 46 | 2010 |
| Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid D Hsu, J Brieva, B Nardone, JI Silverberg British Journal of Dermatology 174 (3), 645-648, 2016 | 39 | 2016 |
